ArticleThe Kaohsiung journal of medical sciences2026
Associations of the Baseline Level and Change in Triglyceride Glucose-Body Roundness Index With Cardiovascular Diseases: Two Large Prospective Cohorts in Europe and Asia.
Article in The Kaohsiung journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The aim of this study was to investigate the association of baseline and changes of TyG-BRI with incident CVD based on the UK Biobank and China Health and Retirement Longitudinal Study (CHARLS). A total of 418,510 and 7923 individuals from the UK Biobank and CHARLS were included in Analysis 1 (baseline TyG-BRI with CVD risk). In Analysis 2 (change in TyG-BRI with CVD risk), a total of 11,682 and 4637 participants were included in Cox proportional hazard models. We found participants with the highest baseline TyG-BRI level were associated with increased risk of incident CVD in UK Biobank (HR = 1.45, 95% CI: 1.39-1.52) and CHARLS (HR = 1.35, 95% CI: 1.13-1.61). Multivariable-adjusted restricted cubic spline analyses presented positive linear associations between TyG-BRI and CVD risk. Compared to persistently low levels of TyG-BRI (Class 1), those with persistently high levels (Class 3: 1.23 (1.02-1.49) and 1.42 (1.11-1.55); Class 4: 1.48 (1.17-1.87) and 1.45 (1.16-2.28); Class 5: 2.58 (1.86-3.58) and 1.63 (1.16-2.28) for UK Biobank and CHARLS) in follow-up were associated with increased risks of incident CVD. In conclusion, a high baseline TyG-BRI level and different changes in TyG-BRI level are associated with increased risks of incident CVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.